These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 3144537

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
    Singlas E, Leroy A, Sultan E, Godin M, Moulin B, Taburet AM, Dhib M, Fillastre JP.
    Clin Pharmacokinet; 1990 Jul; 19(1):67-79. PubMed ID: 2116256
    [Abstract] [Full Text] [Related]

  • 4. Metabolism of fleroxacin in man.
    Sörgel F, Seelmann R, Naber K, Metz R, Muth P.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():169-78. PubMed ID: 3144535
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.
    Nakashima M, Kanamaru M, Uematsu T, Takiguchi A, Mizuno A, Itaya T, Kawahara F, Ooie T, Saito S, Uchida H.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():133-44. PubMed ID: 3144532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I, Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ.
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single and multiple dose pharmacokinetics of fleroxacin.
    Weidekamm E, Portmann R, Partos C, Dell D.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
    [Abstract] [Full Text] [Related]

  • 11. Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Heizmann P, Dell D, Eggers H, Gora R.
    J Chromatogr; 1990 Apr 27; 527(1):91-101. PubMed ID: 2114419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers.
    Sorgel F, Metz R, Naber K, Seelmann R, Muth P.
    J Antimicrob Chemother; 1988 Oct 27; 22 Suppl D():155-67. PubMed ID: 3144534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
    Naber KG, Sörgel F, Kees F, Schumacher H, Metz R, Grobecker H.
    J Antimicrob Chemother; 1988 Oct 27; 22 Suppl D():199-207. PubMed ID: 2462556
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
    Christenson JG, Chan KK, Cleeland R, Dix-Holzknecht B, Farrish HH, Patel IH, Specian A.
    Antimicrob Agents Chemother; 1990 Oct 27; 34(10):1895-900. PubMed ID: 2127171
    [Abstract] [Full Text] [Related]

  • 18. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
    Chukwuani CM, Coker HA, Oduola AM, Sowunmi A, Ifudu ND.
    Biol Pharm Bull; 2000 Aug 27; 23(8):968-72. PubMed ID: 10963305
    [Abstract] [Full Text] [Related]

  • 19. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
    Naber KG, Theuretzbacher U, Kinzig M, Savov O, Sörgel F.
    Antimicrob Agents Chemother; 1998 Jul 27; 42(7):1659-65. PubMed ID: 9661000
    [Abstract] [Full Text] [Related]

  • 20. Penetration of fleroxacin into maxillary sinus mucosa and palatine tonsil.
    Baba S, Mori Y, Maruo T.
    J Antimicrob Chemother; 1988 Oct 27; 22 Suppl D():195-7. PubMed ID: 3144538
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.